449 third-party lab reports published Volume pricing on every peptide, applied automatically in the cart: 3% off 2–3 · 8% off 4–5 · 12% off 6–7 · 15% off 8–9 · 20% off 10–19 · 25% off 20–29 · 30% off 30–39 · 35% off 40+ units · solvents and lab supplies excluded 99.59% median purity across 254 lots 242 / 242 lots pass sterility

‹ Certificates CJC No DAC IPA Blend Lot 1358

Lab report (Certificate of Analysis, COA)

CJC No DAC IPA Blend · 5mg each (10mg total)

Batch 1358 · tested July 29, 2025 (425 days ago) · released May 25, 2026

All tests passed

Batch
#1358 8 tests
Mass
5mg each (10mg total)
Purity
>99.80%
Issuing lab accreditation
Vanguard · ISO 17025:2017 / A2LA #6377.01.01

1 unit tested for purity: >99.80% as printed

Conformity: Not assessable — every reported unit passed on all 6 test rows · QA approval corroborates: Vanguard Laboratory, Tori Johnson, Operations Manager, 2025-07-29

Vanguard · issuing lab

Verified by Vanguard Laboratory

This certificate is also hosted by Vanguard Laboratory — the issuing lab — on its own verification site.

View on VerifiedByVanguard.com
Laboratory ID V250626-13 007

Notes

Content audit 9 Sep 2026: lot 01-018-PD-1358 → 1358. Certificate prints: prints compound "CJC-1295/Ipamorelin", lot "01-018-PD-1358", lab id "V250626-13 007", content CJC-1295: 5.35 mg; Ipamorelin: 5.01 mg

Reports for this lot

  1. Vanguard Laboratory this report · tested July 29, 2025 · 6 results · QA approvalVanguard · issuing labAll tests passed

Test by test

6 results on the report · 4 rows computed from the per-unit values · 1 ISO 17025:2017-accredited lab · each test used up to 2 vials from this lot (rows are not added together) · every row names the chapter or house rule it follows

✓PurityWithin limits
>99.80 · 1 unit · USP <621> (procedural chapter)
–Purity consistency between unitsSingle measurement
1 unit printed (>99.80%) · a between-unit spread needs two or more measured units
✓Net peptide content (assay) · CJC-1295Within limits
5.35 mg · 1 unit · USP <621> (procedural chapter)
✓Net peptide content (assay) · IpamorelinWithin limits
5.01 mg · 1 unit · USP <621> (procedural chapter)
–Content consistency between units · CJC-1295Single measurement
1 unit printed (5.35 mg) · a between-unit spread needs two or more measured units
–Content consistency between units · IpamorelinSingle measurement
1 unit printed (5.01 mg) · a between-unit spread needs two or more measured units
✓Heavy metalsWithin limits
all non-detect · 2 units · dose-scaled limits derived from USP <232> (limits chapter)
–Residual solventsNot on this lot's panel
not on this report · this batch was tested to our earlier standard; newer batches get all 15 tests
–TFA residualNot on this lot's panel
not on this report · this batch was tested to our earlier standard; newer batches get all 15 tests
✓EndotoxinsWithin limits
0.26 EU/vial · 1 unit · USP <85> (procedural chapter)
–Container closureNot on this lot's panel
not on this report · this batch was tested to our earlier standard; newer batches get all 15 tests
–SolubilityNot on this lot's panel
not on this report · this batch was tested to our earlier standard; newer batches get all 15 tests
✓SterilityPass
1 of 1 pass · 1 unit · USP <71> (procedural chapter)
–ConformityNot assessable
every reported unit passed on all 6 test rows · QA approval corroborates: Vanguard Laboratory, Tori Johnson, Operations Manager, 2025-07-29 · house check · agreement across all tests, unit to unit; QA approval corroborates

A chapter number names the method or limit a result follows; it does not describe the product. Chapters below 1000 are procedures or limits; 1000-series chapters are informational. USP <905> is the compendial test for between-unit uniformity: it assays 10 units, so a 3-unit certificate cannot yield its acceptance value — the content row is a house check with <905> named as the reference only.

Tested by Vanguard Laboratory · Released May 25, 2026

Permanent URL: https://peptidology.co/coa/cjc-no-dac-ipa-blend-lot-01-018-pd-1358/

For research use only. Not intended for diagnostic or therapeutic use.

This certificate has been viewed 3 times.